Interstitial Lung Disease Incidence and Cardiotoxicity With Trastuzumab Deruxtecan in Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incidence of interstitial lung disease and cardiotoxicity with trastuzumab deruxtecan in breast cancer patients: a systematic review and single-arm meta-analysis
ESMO Open 2023 Jul 21;8(4)101613, LR Soares, M Vilbert, VDL Rosa, JL Oliveira, MM Deus, R Freitas-JuniorFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.